Kevin Young

2006

In 2006, Kevin Young earned a total compensation of $3.4M as Executive Vice President, Commercial Operations at Gilead Sciences.

Compensation breakdown

Bonus$133,333
Non-Equity Incentive Plan$431,250
Option Awards$2,275,805
Salary$495,833
Other$18,975
Total$3,355,196

Young received $2.3M in option awards, accounting for 68% of the total pay in 2006.

Young also received $133.3K in bonus, $431.3K in non-equity incentive plan, $495.8K in salary and $19K in other compensation.

Rankings

In 2006, Kevin Young's compensation ranked 984th out of 7,022 executives tracked by ExecPay. In other words, Young earned more than 86.0% of executives.

ClassificationRankingPercentile
All
984
out of 7,022
86th
Division
Manufacturing
308
out of 2,413
87th
Major group
Chemicals And Allied Products
53
out of 673
92nd
Industry group
Drugs
31
out of 518
94th
Industry
Biological Products, Except Diagnostic Substances
5
out of 112
96th
Source: SEC filing on March 12, 2009.

Young's colleagues

We found four more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2006.

2006

John Martin

Gilead Sciences

Chief Executive Officer

2006

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2006

John Milligan

Gilead Sciences

Chief Operating Officer

2006

John Toole

Gilead Sciences

Senior Vice President, Clinical Research

In-depth

You may also like